Pfizer Inc. is having difficulty identifying an immune correlate of protection, a measurement of an immune marker that can predict a person’s degree of protection against infection or disease, when inoculated with its COVID-19 vaccine.
A proven correlate would make it easier to license similar vaccines, modify the current vaccine, and expand the populations it...







